Skip to main content
Top
Gepubliceerd in: Quality of Life Research 10/2015

16-04-2015 | Brief Communication

Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer

Auteurs: Carlos K. H. Wong, Edmond P. H. Choi, James H. L. Tsu, Brian S. H. Ho, Ada T. L. Ng, W. Y. Chin, M. K. Yiu

Gepubliceerd in: Quality of Life Research | Uitgave 10/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

The aim of the study was to assess the validity, reliability and sensitivity of the FACT-P (version 4) in Chinese males with prostate cancer.

Methods

Construct validity was assessed using Spearman’s correlation test against the 12-item Short Form Health Survey (SF-12v2). Internal consistency and test–retest reliability were assessed using Cronbach’s α coefficient and intra-class correlation coefficient, respectively. Sensitivity was determined by performing known-group comparisons by independent t test.

Results

FACT-P subscale scores had a moderate correlation with the corresponding SF-12v2 domain score that conceptually measures the similar construct providing evidence for adequate construct validity. Internal consistency was acceptable (α: 0.687–0.900) for all subscales aside from the Prostate Cancer Subscale (α: 0.505) and Trial Outcome Index (α: 0.562). FACT-P subscale and total scores showed good test–retest reliability (range 0.753–0.913). All total scales and most of the subscales were sensitive in detecting differences between patients with different levels of functional impairment but not different cancer stages or levels of prostate-specific antigen.

Conclusions

The measure is a valid and reliable measure to assess the health-related quality of life of Chinese males with prostate cancer. The FACT-P is sensitive to detect difference between patients with varying functional status.
Literatuur
1.
go back to reference Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127(12), 2893–2917.CrossRef Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127(12), 2893–2917.CrossRef
2.
go back to reference Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., et al. (2008). Quality of life and satisfaction with outcome among prostate-cancer survivors. New England Journal of Medicine, 358(12), 1250–1261.CrossRefPubMed Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., et al. (2008). Quality of life and satisfaction with outcome among prostate-cancer survivors. New England Journal of Medicine, 358(12), 1250–1261.CrossRefPubMed
3.
go back to reference Miller, D. C., Sanda, M. G., Dunn, R. L., Montie, J. E., Pimentel, H., Sandler, H. M., et al. (2005). Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. Journal of Clinical Oncology, 23(12), 2772–2780.CrossRefPubMed Miller, D. C., Sanda, M. G., Dunn, R. L., Montie, J. E., Pimentel, H., Sandler, H. M., et al. (2005). Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. Journal of Clinical Oncology, 23(12), 2772–2780.CrossRefPubMed
4.
go back to reference Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., et al. (1995). Quality-of-life outcomes in men treated for localized prostate cancer. JAMA, 273(2), 129–135.CrossRefPubMed Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., et al. (1995). Quality-of-life outcomes in men treated for localized prostate cancer. JAMA, 273(2), 129–135.CrossRefPubMed
5.
go back to reference Schmidt, S., Garin, O., Pardo, Y., Valderas, J., Alonso, J., Rebollo, P., et al. (2014). Assessing quality of life in patients with prostate cancer: A systematic and standardized comparison of available instruments. Quality of Life Research, 23(8), 2169–2181.PubMedCentralCrossRefPubMed Schmidt, S., Garin, O., Pardo, Y., Valderas, J., Alonso, J., Rebollo, P., et al. (2014). Assessing quality of life in patients with prostate cancer: A systematic and standardized comparison of available instruments. Quality of Life Research, 23(8), 2169–2181.PubMedCentralCrossRefPubMed
6.
go back to reference Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11(3), 570–579.PubMed Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11(3), 570–579.PubMed
7.
go back to reference Overcash, J., Extermann, M., Parr, J., Perry, J., & Balducci, L. (2001). Validity and reliability of the FACT-G scale for use in the older person with cancer. American Journal of Clinical Oncology, 24(6), 591–596.CrossRefPubMed Overcash, J., Extermann, M., Parr, J., Perry, J., & Balducci, L. (2001). Validity and reliability of the FACT-G scale for use in the older person with cancer. American Journal of Clinical Oncology, 24(6), 591–596.CrossRefPubMed
8.
go back to reference Webster, K., Cella, D., & Yost, K. (2003). The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health and quality of life outcomes, 1, 79.PubMedCentralCrossRefPubMed Webster, K., Cella, D., & Yost, K. (2003). The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health and quality of life outcomes, 1, 79.PubMedCentralCrossRefPubMed
9.
go back to reference Winstead-Fry, P., & Schultz, A. (1997). Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample. Cancer, 79(12), 2446–2452.CrossRefPubMed Winstead-Fry, P., & Schultz, A. (1997). Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample. Cancer, 79(12), 2446–2452.CrossRefPubMed
10.
go back to reference Esper, P., Hampton, J. N., Smith, D. C., & Pienta, K. J. (1999). Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer. Oncology nursing forum, 26(1), 107–112.PubMed Esper, P., Hampton, J. N., Smith, D. C., & Pienta, K. J. (1999). Quality-of-life evaluation in patients receiving treatment for advanced prostate cancer. Oncology nursing forum, 26(1), 107–112.PubMed
11.
go back to reference Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J. (1997). Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology, 50(6), 920–928.CrossRefPubMed Esper, P., Mo, F., Chodak, G., Sinner, M., Cella, D., & Pienta, K. J. (1997). Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology, 50(6), 920–928.CrossRefPubMed
12.
go back to reference Schag, C. C., Heinrich, R. L., & Ganz, P. (1984). Karnofsky performance status revisited: Reliability, validity, and guidelines. Journal of Clinical Oncology, 2(3), 187–193.PubMed Schag, C. C., Heinrich, R. L., & Ganz, P. (1984). Karnofsky performance status revisited: Reliability, validity, and guidelines. Journal of Clinical Oncology, 2(3), 187–193.PubMed
13.
go back to reference Yu, C. L. M., Fielding, R., Chan, C. L. W., Tse, V. K. C., Choi, P. H. K., Lau, W. H., Choy, D. T. K., Lee, A. W. M., & Sham, J. S. T. (2000). Measuring quality of life of Chinese cancer patients. Cancer, 88(7), 1715–1727. Yu, C. L. M., Fielding, R., Chan, C. L. W., Tse, V. K. C., Choi, P. H. K., Lau, W. H., Choy, D. T. K., Lee, A. W. M., & Sham, J. S. T. (2000). Measuring quality of life of Chinese cancer patients. Cancer, 88(7), 1715–1727.
14.
go back to reference Wong, C. K. H., Lam, C. L. K., Law, W. L., Poon, J. T. C., Chan, P., Kwong, D. L. W., & Tsang, J. (2012). Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm. Journal of Evaluation in Clinical Practice, 18(6), 1186–1195. Wong, C. K. H., Lam, C. L. K., Law, W. L., Poon, J. T. C., Chan, P., Kwong, D. L. W., & Tsang, J. (2012). Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm. Journal of Evaluation in Clinical Practice, 18(6), 1186–1195.
15.
go back to reference Lam, C. L. K., Wong, C. K. H., Lam, E. T. P., Lo, Y. Y. C., & Huang, W. W. (2010). Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner, 32, 77–86. Lam, C. L. K., Wong, C. K. H., Lam, E. T. P., Lo, Y. Y. C., & Huang, W. W. (2010). Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner, 32, 77–86.
16.
go back to reference Lam, C. L., Tse, E. Y., & Gandek, B. (2005). Is the standard SF-12 health survey valid and equivalent for a Chinese population? Quality of life Research, 14(2), 539–547.CrossRefPubMed Lam, C. L., Tse, E. Y., & Gandek, B. (2005). Is the standard SF-12 health survey valid and equivalent for a Chinese population? Quality of life Research, 14(2), 539–547.CrossRefPubMed
17.
go back to reference Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill. Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill.
18.
go back to reference Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMed Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMed
19.
go back to reference Churchill, G. A., Jr. (1979). A paradigm for developing better measures of marketing constructs. Journal of marketing research, 16(1), 64–73. Churchill, G. A., Jr. (1979). A paradigm for developing better measures of marketing constructs. Journal of marketing research, 16(1), 64–73.
20.
go back to reference Zhou, H. J., So, J. B., Yong, W. P., Luo, N., Zhu, F., Naidoo, N., et al. (2012). Validation of the functional assessment of cancer therapy-gastric module for the Chinese population. Health and Quality of Life Outcomes, 10, 145.PubMedCentralCrossRefPubMed Zhou, H. J., So, J. B., Yong, W. P., Luo, N., Zhu, F., Naidoo, N., et al. (2012). Validation of the functional assessment of cancer therapy-gastric module for the Chinese population. Health and Quality of Life Outcomes, 10, 145.PubMedCentralCrossRefPubMed
21.
go back to reference Schag, C. A., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, J. J. (1994). Quality of life in adult survivors of lung, colon and prostate cancer. Quality of Life Research, 3(2), 127–141.CrossRefPubMed Schag, C. A., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, J. J. (1994). Quality of life in adult survivors of lung, colon and prostate cancer. Quality of Life Research, 3(2), 127–141.CrossRefPubMed
22.
go back to reference Alibhai, S. M., Breunis, H., Timilshina, N., Johnston, C., Tomlinson, G., Tannock, I., et al. (2010). Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. Journal of Clinical Oncology, 28(34), 5038–5045.CrossRefPubMed Alibhai, S. M., Breunis, H., Timilshina, N., Johnston, C., Tomlinson, G., Tannock, I., et al. (2010). Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. Journal of Clinical Oncology, 28(34), 5038–5045.CrossRefPubMed
23.
go back to reference Galvao, D. A., Taaffe, D. R., Spry, N., Joseph, D., Turner, D., & Newton, R. U. (2009). Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: A comprehensive cross-sectional investigation. Prostate Cancer and Prostatic Diseases, 12(2), 198–203.CrossRefPubMed Galvao, D. A., Taaffe, D. R., Spry, N., Joseph, D., Turner, D., & Newton, R. U. (2009). Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: A comprehensive cross-sectional investigation. Prostate Cancer and Prostatic Diseases, 12(2), 198–203.CrossRefPubMed
24.
go back to reference Storer, T. W., Miciek, R., & Travison, T. G. (2012). Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy. Asian Journal of Andrology, 14(2), 204–221.PubMedCentralCrossRefPubMed Storer, T. W., Miciek, R., & Travison, T. G. (2012). Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy. Asian Journal of Andrology, 14(2), 204–221.PubMedCentralCrossRefPubMed
25.
go back to reference Chie, W.-C., Yu, C.-C., & Yu, H.-J. (2010). Reliability and validity of the Taiwan Chinese version of the EORTC QLQ-PR25 in assessing quality of life of prostate cancer patients. Urological Science, 21(3), 118–125.CrossRef Chie, W.-C., Yu, C.-C., & Yu, H.-J. (2010). Reliability and validity of the Taiwan Chinese version of the EORTC QLQ-PR25 in assessing quality of life of prostate cancer patients. Urological Science, 21(3), 118–125.CrossRef
Metagegevens
Titel
Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer
Auteurs
Carlos K. H. Wong
Edmond P. H. Choi
James H. L. Tsu
Brian S. H. Ho
Ada T. L. Ng
W. Y. Chin
M. K. Yiu
Publicatiedatum
16-04-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-0993-8

Andere artikelen Uitgave 10/2015

Quality of Life Research 10/2015 Naar de uitgave